0001140361-22-008670.txt : 20220309 0001140361-22-008670.hdr.sgml : 20220309 20220309175837 ACCESSION NUMBER: 0001140361-22-008670 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220307 FILED AS OF DATE: 20220309 DATE AS OF CHANGE: 20220309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grossman Jerrold B CENTRAL INDEX KEY: 0001542519 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36728 FILM NUMBER: 22726623 MAIL ADDRESS: STREET 1: 65 COMMERCE WAY CITY: HACKENSACK STATE: NJ ZIP: 07601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADMA BIOLOGICS, INC. CENTRAL INDEX KEY: 0001368514 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 562590442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O ADMA BIOLOGICS, INC. STREET 2: 465 STATE ROUTE 17 CITY: RAMSEY STATE: NJ ZIP: 07446 BUSINESS PHONE: (201) 478-5552 MAIL ADDRESS: STREET 1: C/O ADMA BIOLOGICS, INC. STREET 2: 465 STATE ROUTE 17 CITY: RAMSEY STATE: NJ ZIP: 07446 FORMER COMPANY: FORMER CONFORMED NAME: R&R ACQUISITION VI, INC DATE OF NAME CHANGE: 20060707 4 1 form4.xml FORM 4 X0306 4 2022-03-07 0001368514 ADMA BIOLOGICS, INC. ADMA 0001542519 Grossman Jerrold B C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 true Common Stock 2022-03-07 4 A 0 26586 0 A 287450 D Common Stock 22857 I See footnote Common Stock 31381 I See footnote Common Stock 38294 I See footnote Common Stock 175 I See footnote Employee Stock Option (right to buy) 1.67 2022-03-07 4 A 0 53172 0 A 2032-03-07 Common Stock 53172 53172 D These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date. Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 260,864 shares of common stock owned by the reporting person. These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood. These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee. These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis. These shares are owned by the reporting person's wife. The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant. /s/ Dr. Jerrold B. Grossman, by Brian Lenz as Attorney-in-fact 2022-03-09